Wang Y, Wei W, Zhang Y, Miao J, Bao X, Lu C
Front Pharmacol. 2025; 16:1512968.
PMID: 40070567
PMC: 11893596.
DOI: 10.3389/fphar.2025.1512968.
Pulica R, Aquib A, Varsanyi C, Gadiyar V, Wang Z, Frederick T
Cell Commun Signal. 2025; 23(1):131.
PMID: 40069722
PMC: 11900106.
DOI: 10.1186/s12964-025-02090-6.
Thoenen E, Ranjan A, Parrales A, Nishikawa S, Dixon D, Oka S
Nat Commun. 2025; 16(1):2365.
PMID: 40064891
PMC: 11894096.
DOI: 10.1038/s41467-025-57539-6.
Liu Z, Liu Y, Kang X, Li L, Xiang Y
Pharmaceutics. 2025; 17(2).
PMID: 40006565
PMC: 11859411.
DOI: 10.3390/pharmaceutics17020198.
Chien H, Hu H, Tsai S, Lin C, Yang S, Chen J
Antioxidants (Basel). 2025; 14(2).
PMID: 40002335
PMC: 11851460.
DOI: 10.3390/antiox14020148.
The Mechanism of Acupuncture Regulating Autophagy: Progress and Prospect.
He J, He M, Sun M, Chen H, Dou Z, Nie R
Biomolecules. 2025; 15(2).
PMID: 40001566
PMC: 11852493.
DOI: 10.3390/biom15020263.
PERK-Olating Through Cancer: A Brew of Cellular Decisions.
Mazzolini L, Touriol C
Biomolecules. 2025; 15(2).
PMID: 40001551
PMC: 11852789.
DOI: 10.3390/biom15020248.
RNA exosome-driven RNA processing instructs the duration of the unfolded protein response.
Matabishi-Bibi L, Goncalves C, Babour A
Nucleic Acids Res. 2025; 53(4).
PMID: 39995043
PMC: 11850225.
DOI: 10.1093/nar/gkaf088.
In vitro analysis of the molecular mechanisms of ursolic acid against ovarian cancer.
Zhang R, Zhang Z, Xie L, Yu Z, Gao R, Zhang Z
BMC Complement Med Ther. 2025; 25(1):65.
PMID: 39984915
PMC: 11846399.
DOI: 10.1186/s12906-025-04808-y.
Small molecule-mediated inhibition of the oxidoreductase ERO1A restrains aggressive breast cancer by impairing VEGF and PD-L1 in the tumor microenvironment.
Varone E, Retini M, Cherubini A, Chernorudskiy A, Marrazza A, Guidarelli A
Cell Death Dis. 2025; 16(1):105.
PMID: 39962052
PMC: 11833095.
DOI: 10.1038/s41419-025-07426-1.
The Interplay Between Endoplasmic Reticulum Stress and Ferroptosis in Neurological Diseases.
Zhai T, Wang B, Shi C, Zhang C, Shen J, Feng X
Neurochem Res. 2025; 50(2):99.
PMID: 39928173
DOI: 10.1007/s11064-025-04348-4.
Relocating NSAIDs into the endoplasmic reticulum induces ER stress-mediated apoptosis in cancer cells.
Mishra T, Preeti , Ingle J, Saha A, Basu S
RSC Med Chem. 2025; .
PMID: 39911136
PMC: 11791515.
DOI: 10.1039/d4md00936c.
Regulation of ER stress-induced apoptotic and inflammatory responses via YAP/TAZ-mediated control of the TRAIL-R2/DR5 signaling pathway.
El Yousfi Y, Fernandez-Farran F, Oliver F, Lopez-Rivas A, Yerbes R
Cell Death Discov. 2025; 11(1):42.
PMID: 39904986
PMC: 11794427.
DOI: 10.1038/s41420-025-02335-w.
Applications and enhancement strategies of ROS-based non-invasive therapies in cancer treatment.
Guo Q, Tang Y, Wang S, Xia X
Redox Biol. 2025; 80:103515.
PMID: 39904189
PMC: 11847112.
DOI: 10.1016/j.redox.2025.103515.
Sigma1 inhibitor suppression of adaptive immune resistance mechanisms mediated by cancer cell derived extracellular vesicles.
Castagnino P, Haas D, Musante L, Tancler N, Tran B, Kean R
Cancer Biol Ther. 2025; 26(1):2455722.
PMID: 39863992
PMC: 11776462.
DOI: 10.1080/15384047.2025.2455722.
Mechanistic Insights into the Anticancer Potential of Methoxyflavones Analogs: A Review.
Aidiel M, Abdul Mutalib M, Ramasamy R, Nik Ramli N, Tang S, Adam S
Molecules. 2025; 30(2).
PMID: 39860214
PMC: 11768088.
DOI: 10.3390/molecules30020346.
Gut microbiota derived metabolite trimethylamine N-oxide influences prostate cancer progression via the p38/HMOX1 pathway.
Zhou Y, Lv J, Jin S, Fu C, Liu B, Shen Y
Front Pharmacol. 2025; 15():1526051.
PMID: 39850572
PMC: 11754881.
DOI: 10.3389/fphar.2024.1526051.
Construction of a radiogenomic signature based on endoplasmic reticulum stress for predicting prognosis and systemic combination therapy response in hepatocellular carcinoma.
Wu H, Cao S, Xu Z, Wang T, Ji G, Wang K
BMC Cancer. 2025; 25(1):131.
PMID: 39849389
PMC: 11756198.
DOI: 10.1186/s12885-025-13433-4.
LINC00626 drives tamoxifen resistance in breast cancer cells by interaction with UPF1.
Yuan H, Zhou L, Hu W, Yang M
Sci Rep. 2025; 15(1):2997.
PMID: 39848992
PMC: 11757752.
DOI: 10.1038/s41598-025-86287-2.
The endoplasmic reticulum degradation-enhancing α-mannosidase-like protein 3 attenuates the unfolded protein response and has pro-survival and pro-viral roles in hepatoma cells and hepatocellular carcinoma patients.
Ghionescu A, Uta M, Sorop A, Lazar C, Flintoaca-Alexandru P, Chiritoiu G
J Biomed Sci. 2025; 32(1):11.
PMID: 39838427
PMC: 11752926.
DOI: 10.1186/s12929-024-01103-9.